COMMONWEALTH EQUITY SERVICES, LLC - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 35 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$24,000
-51.0%
90,510
+3.4%
0.00%
Q2 2022$49,000
-14.0%
87,5100.0%0.00%
Q1 2022$57,000
-38.7%
87,5100.0%0.00%
Q4 2021$93,000
-47.8%
87,510
-36.4%
0.00%
Q3 2021$178,000
-34.8%
137,5100.0%0.00%
-100.0%
Q2 2021$273,000
-18.3%
137,510
+10.9%
0.00%0.0%
Q1 2021$334,000
+642.2%
124,049
+716.3%
0.00%
Q4 2020$45,00015,1970.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
QS Investors, LLC 82,000$247,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders